Cargando…

NRF2-Related Epigenetic Modifications in Cardiac and Vascular Complications of Diabetes Mellitus

Diabetes mellitus (DM) is a highly prevalent chronic disease that is accompanied with serious complications, especially cardiac and vascular complications. Thus, there is an urgent need to identify new strategies to treat diabetic cardiac and vascular complications. Nuclear factor erythroid 2-relate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jie, Xiao, Mengjie, Wang, Shudong, Zhang, Jingjing, Guo, Yuanfang, Tang, Yufeng, Gu, Junlian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269153/ https://www.ncbi.nlm.nih.gov/pubmed/34248833 http://dx.doi.org/10.3389/fendo.2021.598005

Ejemplares similares

Epigenetic Regulation Associated With Sirtuin 1 in Complications of Diabetes Mellitus
por: Wang(a), Jie, et al.
Publicado: (2021)

The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms
por: Xiao, Mengjie, et al.
Publicado: (2021)

Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes
por: Khullar, Madhu, et al.
Publicado: (2017)

Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2
por: Wang(a), Jie, et al.
Publicado: (2022)

Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway
por: Lu, Guangping, et al.
Publicado: (2022)

Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction via AKT/GSK3β/FYN-Mediated NRF2 Activation
por: Xuan, Yue, et al.
Publicado: (2022)

Vascular Complication in Adolescents With Diabetes Mellitus
por: Graves, Lara E., et al.
Publicado: (2020)

The transcriptomic and epigenetic alterations in type 2 diabetes mellitus patients of Chinese Tibetan and Han populations
por: Wang, Xian, et al.
Publicado: (2023)

Co-Treatment With Resveratrol and FGF1 Protects Against Acute Liver Toxicity After Doxorubicin Treatment via the AMPK/NRF2 Pathway
por: Xu, Xianchou, et al.
Publicado: (2022)

Epigenetic modification in diabetic kidney disease
por: Liu, Zhe, et al.
Publicado: (2023)

The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
por: Wang, Yu, et al.
Publicado: (2022)

Epigenetics of methylation modifications in diabetic cardiomyopathy
por: Hao, Jing, et al.
Publicado: (2023)

Sulforaphane prevents angiotensin II‐induced cardiomyopathy by activation of Nrf2 through epigenetic modification
por: Su, Xuling, et al.
Publicado: (2021)

p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act
por: Guo, Yuanfang, et al.
Publicado: (2023)

The Role of NRF2 in Bone Metabolism – Friend or Foe?
por: Han, Jie, et al.
Publicado: (2022)

Non-Invasive Detection of Fetal Vascular Endothelial Function in Gestational Diabetes Mellitus
por: Chen, Yunyu, et al.
Publicado: (2021)

Epigenetics Modifications and Therapeutic Prospects in Human Thyroid Cancer
por: Catalano, Maria Graziella, et al.
Publicado: (2012)

Active Moderate-to-Severe Graves' Orbitopathy in a Patient With Type 2 Diabetes Mellitus and Vascular Complications
por: Urselli, Francesca, et al.
Publicado: (2019)

Histone Lysine Methylation Modification and Its Role in Vascular Calcification
por: Cao, Ye-Chi, et al.
Publicado: (2022)

A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity
por: Xiao, Mengjie, et al.
Publicado: (2021)

Genetics and Epigenetics: New Insight on Gestational Diabetes Mellitus
por: Dalfrà, Maria Grazia, et al.
Publicado: (2020)

Association of Polymorphisms in miRNA Processing Genes With Type 2 Diabetes Mellitus and Its Vascular Complications in a Southern Chinese Population
por: Wen, Zihao, et al.
Publicado: (2019)

Correlation of thyroid-related hormones with vascular complications in type 2 diabetes patients with euthyroid
por: Lin, Jie, et al.
Publicado: (2022)

A systematic bibliometric analysis on the clinical practice of CGM in diabetes mellitus from 2012 to 2022
por: Kong, Laixi, et al.
Publicado: (2023)

The Utility of Exosomes in Diagnosis and Therapy of Diabetes Mellitus and Associated Complications
por: Sun, Yaoxiang, et al.
Publicado: (2021)

Exosomes: Biomarkers and Therapeutic Targets of Diabetic Vascular Complications
por: Chen, Anqi, et al.
Publicado: (2021)

Prevalence and risk factors of vascular complications in type 2 diabetes mellitus: Results from discover Middle East and Africa cohort
por: Hafidh, Khadija, et al.
Publicado: (2022)

Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links
por: De Rosa, Salvatore, et al.
Publicado: (2018)

Association of Diabetes Mellitus With Postoperative Complications and Mortality After Non-Cardiac Surgery: A Meta-Analysis and Systematic Review
por: Zhang, Xiaoying, et al.
Publicado: (2022)

Circular RNAs in diabetes mellitus and its complications
por: Fan, Wenqi, et al.
Publicado: (2022)

Editorial: Ocular complications associated with diabetes mellitus
por: Zhang, Xinyuan, et al.
Publicado: (2023)

Mechanistic Insights Into the Interaction Between Transcription Factors and Epigenetic Modifications and the Contribution to the Development of Obesity
por: Huang, Qi, et al.
Publicado: (2018)

Evaluating All Potential Oral Complications of Diabetes Mellitus
por: Verhulst, Martijn J. L., et al.
Publicado: (2019)

Emerging Role of Epitranscriptomics in Diabetes Mellitus and Its Complications
por: Geng, Xinqian, et al.
Publicado: (2022)

Genomic DNA Methylation in Diabetic Chronic Complications in Patients With Type 2 Diabetes Mellitus
por: Wang, Xixi, et al.
Publicado: (2022)

Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy
por: Gu, Junlian, et al.
Publicado: (2017)

Exploring exercise-driven inhibition of pyroptosis: novel insights into treating diabetes mellitus and its complications
por: Li, Nan, et al.
Publicado: (2023)

Trimethylaminuria and Vascular Complications
por: Oliveira-Filho, Antonio Fernandes, et al.
Publicado: (2021)

Nomogram Prediction for the Risk of Diabetic Foot in Patients With Type 2 Diabetes Mellitus
por: Wang, Jie, et al.
Publicado: (2022)

Text mining-based identification of promising miRNA biomarkers for diabetes mellitus
por: Li, Xin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_id0v8kk0ve2obtsnmirr4r11m4